Please assess the completion status of the following clinical trial:

Trial Title: Effects of Intravenous Acetaminophen on Body Temperature and Hemodynamic Responses in Febrile Critically Ill Adults

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years of age and older~* Patient in an intensive care unit~* Weight greater or equal to 50 kgs~* Fever: core body temperature greater than or equal to 38.3 degrees Celsius~* Clinically stable: no active resuscitation with fluids, blood products, or dose increases of vasoactive medications within 1 hour of study drug administration~Exclusion Criteria:~* Acetaminophen hypersensitivity~* Acute liver failure or acute liver injury~* Heat stroke, malignant hyperthermia, neuroleptic malignant syndrome~* Therapeutic cooling, physical cooling, extracorporeal blood circuit therapies~* Administration of acetaminophen-containing medications, non-steroidal anti-inflammatory drugs, or aspirin greater than 81 mg within specified times per drug prior to fever presentation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Normal saline placebo (Type: PLACEBO_COMPARATOR): Normal saline 100 mLs intravenous, administered over 15 minutes
- Acetaminophen (Type: EXPERIMENTAL): Acetaminophen 1 gram/100 mLs intravenous, single dose administered over 15 minutes

Based on this trial design, predict the completion outcome and termination type (if applicable).